Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in three upcoming events in October:
•Leerink Partners Rare Disease Roundtable at Le Parker Meridien Hotel in New York on Wednesday, October 1. Epizyme CEO Robert Gould, Ph.D., will participate in a fireside chat presentation at 9:15 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
